Search results
What You Should Know About Medications for Osteoporosis
Verywell Health via Yahoo News· 1 year agoMedically reviewed by Stella Bard, MD There are many medication options to treat osteoporosis, a...
Amgen Inc. (NASDAQ:AMGN) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoAmgen Inc. (NASDAQ:AMGN) Q3 2023 Earnings Call Transcript October 31, 2023 Operator: My name is...
US FDA adds 'boxed warning' for Amgen's bone loss drug Prolia
Reuters via Yahoo News· 5 months agoThe so-called boxed warning, issued on Friday, comes after the health regulator in 2022 started a...
Q4 2023 Amgen Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants David M. Reese; Executive VP & CTO; Amgen Inc. James E. Bradner; Executive VP of Research and Development & Chief Scientific Officer; Amgen Inc. Justin Claeys Murdo Gordon; Executive ...
Community Health (CYH) Q4 Earnings Miss, Revenues Up Y/Y
Zacks via Yahoo Finance· 3 months agoCommunity Health Systems, Inc. CYH reported fourth-quarter 2023 adjusted loss of 41 cents per share,...
Here's Why Amgen (AMGN) Stock is Outperforming the Industry
Zacks via Yahoo Finance· 2 months agoAmgen (AMGN) expects strong sales growth of products like Tezspire, Evenity and Repatha to make up...
Radius (RDUS), Menarini Submit NDA for Breast Cancer Drug
Zacks via Yahoo Finance· 2 years agoRadius (RDUS) and partner The Menarini Group submit a new drug application to the FDA for...
Radius (RDUS) to Go Private With $890M Deal, Shares Gain
Zacks via Yahoo Finance· 2 years agoRadius Health RDUS recently announced that it has entered into a definitive agreement to be acquired...
Reclast vs. Prolia: Similarities and Differences
Verywell Health via Yahoo News· 4 months agoIf you have osteoporosis, your healthcare provider may prescribe Reclast (zoledronic acid) or Prolia (denosumab). Both medications are approved by the...
2 Rock-Solid Dividend Stocks to Buy Right Now
Motley Fool· 2 years agoDividend stocks are an equity class for all seasons. Speaking to this point, several blue chip dividend stocks have not only weathered the broad downturn...
